Barclays analyst Carter Could reiterated an Overweight rating and $913.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE